Home
Madrigal Pharmaceuticals MDGL paid Crossroads Strategies $50K for lobbying in Q2 2026 · Medicare, Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q2 2026
- Client
- Madrigal Pharmaceuticals
- Reported
- 26/07/19
Up 0.0% from last quarter
What else happened in Madrigal Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 05/31~07/30Madrigal Pharmaceuticals's other lobbying reports
- Madrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
MDGL
$380K
$380K
Reported 07/20
for Q2
- Madrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
MDGL
$60K
$60K
Reported 07/16
for Q2
- Madrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
MDGL
$120K
$120K
Reported 07/15
for Q2
- Madrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
MDGL
$380K
$380K
Reported 04/24
for Q1
- Madrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
MDGL
$50K
$50K
Reported 04/20
for Q1